Edition:
United States

Interpace Diagnostics Group Inc (IDXG.OQ)

IDXG.OQ on NASDAQ Stock Exchange Capital Market

0.92USD
15 Dec 2017
Change (% chg)

$-0.01 (-1.21%)
Prev Close
$0.93
Open
$0.95
Day's High
$0.98
Day's Low
$0.92
Volume
104,405
Avg. Vol
313,902
52-wk High
$14.24
52-wk Low
$0.72

Select another date:

Mon, Nov 13 2017

BRIEF-Interpace Diagnostics says Q3 sales up 27 pct

* Interpace diagnostics group reports third quarter 2017 financial results, business progress and recent accomplishments

BRIEF-Interpace Diagnostics announces increased reimbursement for ThyGenX

* Interpace Diagnostics Group - ‍reimbursement for ThyGenx molecular test for indeterminate thyroid nodules will increase by 40% starting Jan 1, 2018​ Source text for Eikon: Further company coverage:

BRIEF-Interpace Diagnostics ‍launches new lung cancer test MVPdX​

* Interpace Diagnostics Group Inc - ‍Launch of a new lung cancer test MVPdX​ Source text for Eikon: Further company coverage:

BRIEF-Interpace Diagnostics Group Inc - ‍ assigned a new, discreet CPT code to facilitate reimbursement of Thyramir​

* Interpace Diagnostics Group Inc - ‍ assigned a new, discreet CPT code to facilitate reimbursement of Thyramir​

BRIEF-Interpace Diagnostics announces renewal and extension of LabCorp national agreement

* Interpace Diagnostics announces renewal and extension of LabCorp national agreement

BRIEF-Interpace Diagnostics reports Q2 ‍loss per share from cont ops of $0.65

* Interpace Diagnostics Group reports second quarter 2017 financial results, business progress and recent accomplishments

BRIEF-Interpace Diagnostics launches product extension at world conference on thyroid cancer

* Interpace Diagnostics launches product extension at world conference on thyroid cancer Source text for Eikon: Further company coverage:

BRIEF-Interpace Diagnostics says Cigna agreed to cover co's ThyGenx test for Cigna members

* Interpace diagnostics group inc - cigna agreed to cover interpace's thygenx test for cigna members nationwide, with coverage effective immediately Source text for Eikon: Further company coverage:

BRIEF-Interpace Diagnostics announces national contract with Aetna

* Interpace Diagnostics announces national contract with Aetna

BRIEF-Interpace Diagnostics announces coverage of thyroid test by Premera Blue Cross

* Interpace Diagnostics Group - Premera Blue cross agreed to cover co's Thyramir test for members located primarily in Washington, Oregon, and Alaska Source text for Eikon: Further company coverage:

Select another date: